Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGM | AMGN | VRTX | BMY | REGN |
| Company | Ngm Biopharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.5600 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 1.5700 | 322.60 | 405.67 | 44.33 | 951.91 |
| Low | 1.5400 | 310.65 | 397.59 | 43.69 | 926.94 |
| Last | 1.5400 | 312.66 | 401.44 | 43.89 | 953.03 |
| Change | -0.0200 | +34.27 | +1.28 | +0.19 | +15.42 |
| % Change | -1.28% | +12.31% | +0.32% | +0.43% | +1.64% |
| Volume | 2,390,800 | 7,214,054 | 526,169 | 6,972,339 | 222,946 |
| 20-Day Average Volume | 1,155,695 | 2,518,276 | 994,469 | 14,172,068 | 502,036 |
| Previous Close | 1.5600 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5540 | 272.29 | 398.48 | 47.46 | 909.54 |
| 20-Day Raw Stochastic | 18.18% | 82.48% | 68.95% | 6.43% | 98.06% |
| 20-Day Relative Strength | 51.62% | 72.26% | 47.91% | 28.52% | 57.54% |
| Weighted Alpha | -65.03 | +34.02 | +14.72 | -36.91 | +25.52 |
| Today's Opinion | 32% Buy | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 64% Buy | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 16% Buy | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.94% since 03/27/24 | +15.47% since 04/26/24 | +1.14% since 04/26/24 | -2.19% since 04/26/24 | +7.61% since 04/26/24 |
| Low | 1.5400 on 04/04/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 1.6000 on 03/28/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 951.91 on 05/03/24 |
| 1-Month | |||||
| %Chg | +1.32% since 03/04/24 | +13.60% since 04/03/24 | -1.67% since 04/03/24 | -15.93% since 04/03/24 | -0.06% since 04/03/24 |
| Low | 1.5200 on 03/11/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 1.6300 on 03/27/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | +29.41% since 01/04/24 | -3.54% since 02/02/24 | -5.34% since 02/02/24 | -9.94% since 02/02/24 | +0.55% since 02/02/24 |
| Low | 1.1800 on 01/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 2.2000 on 02/22/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +27.27% since 10/04/23 | +15.52% since 11/03/23 | +6.86% since 11/03/23 | -16.94% since 11/03/23 | +16.35% since 11/03/23 |
| Low | 0.6002 on 11/17/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 2.2000 on 02/22/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 128,531 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 83,462 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 4,420,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -142,380,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 160,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -27,670,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.27 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 03/11/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |